August 2, 2014

Jonathan L. Kravetz

Jon is Chair of the Securities Practice Group and one of the core members of the Life Sciences Practice Group. He represents clients in both public and privately placed equity and debt financings under the Securities Act of 1933, provides counseling for public companies with respect to the full range of securities compliance issues under the Securities Exchange Act of 1934, and advises high-technology, biotechnology, and medical device companies in numerous contractual and strategic matters.

Jon has an active international practice, representing European companies in merger and acquisition, financing, and other transactions with US and non-US companies.

Articles in the National Law Review database by Jonathan L. Kravetz

LATEST LEGAL NEWS & ANALYSIS

Bilzin Sumberg Baena Price & Axelrod LLP

TRENDING LEGAL ANALYSIS